Iodohippurate

CHEMBL1681 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
305.1 g/mol
LogP
1.0
Phase
4

This iodine-labeled compound is used in nuclear medicine kidney studies because it is actively secreted by kidney tubules, making it useful for measuring kidney blood flow and tubular function. When labeled with radioactive iodine, it allows doctors to evaluate how well each kidney is working.

Molekularmasse

305,0700 g/mol

LogP

1,00

TPSA

66,40 Ų

Lipinski-Regel der Fünf

Bestanden

Therapeutische Bereiche

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C(O)CNC(=O)c1ccccc1I

InChI

InChI=1S/C9H8INO3/c10-7-4-2-1-3-6(7)9(14)11-5-8(12)13/h1-4H,5H2,(H,11,14)(H,12,13)

Molecular Formula

C9H8INO3

HBD / HBA

2 / 3

Rotierbare Bindungen

3

Schwere Atome

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

This iodine-labeled compound is used in nuclear medicine kidney studies because it is actively secreted by kidney tubules, making it useful for measuring kidney blood flow and tubular function. When labeled with radioactive iodine, it allows doctors to evaluate how well each kidney is working.

Yes, Iodohippurate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1681. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 8614. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.